AI
VBIV

ArchPoint Investors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

ArchPoint Investors’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,167
Closed -$46K – 62
2022
Q3 		$46K Hold
2,167
– – 0.02% 58
2022
Q2 		$53K Hold
2,167
– – 0.02% 57
2022
Q1 		$108K Hold
2,167
– – 0.04% 59
2021
Q4 		$152K Hold
2,167
– – 0.05% 64
2021
Q3 		$202K Hold
2,167
– – 0.06% 109
2021
Q2 		$218K Sell
2,167
-500
-19% -$48.7K 0.07% 47
2021
Q1 		$249K Hold
2,667
– – 0.07% 79
2020
Q4 		$220K Buy
2,667
+500
+23% +$42.6K 0.06% 81
2020
Q3 		$186K Buy
+2,167
New +$253K 0.06% 79

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return